The facility is brand new. The company has developed various vaccines but yet to undertake commercial production. There is scope with immense potential to roll out own vaccines or contract manufacture for other companies. Both for domestic and export clients. All details will be provided to potential buyer.
The expected valuation is Rs 45 Crs. Potential Buyers with budget only may reach out to me.
Business Brokers and Intermediates please do not reach out.
